APP下载

自拟补脾强肾生血汤治疗早中期慢性肾衰贫血的疗效观察

2017-11-14杜培亮

中国医学创新 2017年25期

杜培亮

【摘要】 目的:研究补脾强肾生血汤治疗早中期慢性肾衰贫血的临床疗效,讨论中医药治疗该病的作用机理。方法:选取2012年9月-2014年9月本院西医诊断为肾性贫血,中医辨证为脾肾气血两虚的患者共30例,采用随机数字表法分为观察组和对照组,每组15例。对照组给以重组人促红素注射液(rHuEPO,CHO细胞)等治疗,对照组在观察组用药基础上给予自拟补脾强肾生血汤口服,两组均治疗56 d。比较患者治疗前后血红蛋白(Hb)、红细胞计数(RBC)、红细胞压积(HCT),血肌酐(Scr)、尿素氮(BUN)及常规检查结果。结果:治疗后观察组RBC、Hb、Scr、BUN水平均优于对照组,差异均有统计学意义(P<0.05),两组治疗前后一般检查结果比较,差异无统计学意义(P>0.05)。结论:采用自拟补脾强肾生血汤治疗早中期慢性肾衰贫血,能够短时间内纠正患者的贫血状况,并可延缓肾功进一步恶化的进程。

【关键词】 慢性肾衰; 肾性贫血; 补脾强肾生血汤; 疗效观察

【Abstract】 Objective:To study the effect of Spleen Qiangshen Shengxue Decoction on the early and middle stage chronic renal failure anemia and discuss the mechanism of TCM treatment.Method:From September 2012 to September 2014,30 patients diagnosed as renal anemia by western medicine and spleen and kidney qi-blood deficiency by TCM were divided into control group and observation group.The control group was given recombinant human erythropoietin injection(rHuEPO,CHO cells) and other treatment,observation group was given Spleen Qiangshen Shengxue Decoction on the basis of control group.Both groups were treated 56 days,the changes of hemoglobin (Hb),red blood cell count(RBC),hematocrit(HCT),serum creatinine(Scr),blood urea nitrogen(BUN) and result of routine examination.Result:Hb,RBC,Scr and BUN of observation group were all better than those of control group,the differences were statistically significant(P<0.05),and there were no significant differences of routine examination result of two groups(P>0.05).Conclusion:Spleen Qiangshen Shengxue Decoction can improve the anemia of patients with chronic renal failure,and delay the process of further deterioration of renal function.

【Key words】 Chronic renal failure; Renal anemia; Spleen Qiangshen Shengxue Decoction; Curative effect observation

First-authors address:Traditional Chinese Medicine Hospital of Langzhong City,Langzhong 637400,China

doi:10.3969/j.issn.1674-4985.2017.25.035

現代医学对早中期慢性肾衰贫血(RA)的治疗着重是使用重组人促红素注射液(CHO细胞)[1],但长时间大剂量皮下或静脉注射,患者多有不便且花费昂贵难以承受。笔者在总结中医药治疗肾性贫血疗效的基础上,根据长期实践观察,自拟补脾强肾生血汤治疗RA[2](不包括替代疗法患者),收到了较好疗效,现报道如下。

1 资料与方法

1.1 一般资料 选取于2012年9月-2014年9月四川省阆中市中医医院中医肾内科住院中心及门诊符合纳入诊断标准的早中期慢性肾衰贫血患者

30例,其中男16例,女14例。年龄20~72岁,平均(51.12±15.84)岁。采用随机数字表法分为对照组和观察组,每组各15例。其中对照组男8例,女7例;……

登录APP查看全文